Hemp Synergistics, a biotech company dedicated to transforming the way manufacturers use hemp-derived cannabinoid-based formulations today announced the addition of Charlie Batch to their Advisory Board.
The addition of Batch to the Hemp Synergistics team is one of many recent successes for the company. Mr. Batch is an entrepreneur whose company, Impellia, brings state-of-the-art sports medicine and rehabilitation technologies to everyone. As Co-Founder, Mr. Batch and his partners have brought to market tech innovations from the University of Michigan, the University of Pittsburgh, and the University of Colorado, among others.
His interest in sports medicine extends to research as well. Mr. Batch is a Player Advisor on the Football Players Health Study at Harvard University. Additionally, he serves as an Advisory Council Member for the University of Pittsburgh Brain Institute.
